Antibodies against tumor-associated antigenic target (tat) polypeptides
CA 2633171 C · Owner: Frantz, Gretchen · Inventors: Hillan, Kenneth J.; Frantz, Gretchen; Smith, Victoria
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same. The present invention discloses the Tumor--associated Antigenic Target (TAT) polypeptide TAT210 (SEQ ID NO: 85) and , discloses uses of anti-TAT210 antibodies antibody fragments and conjugates , for inhibiting the growth of a colorectal cancer cell and for the diagnosis of the presence , of a colorectal tumor in a mammal.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 19, 2002 and granted November 20, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 19, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 19, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.